Universal Ibogaine (FRA:JC4) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Jan. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Universal Ibogaine's net issuance of preferred for the three months ended in Jan. 2025 was €0.00 Mil. The number is 0, which means that Universal Ibogaine has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Universal Ibogaine's net issuance of preferred for the trailing twelve months (TTM) ended in Jan. 2025 was €0.00 Mil.

Universal Ibogaine Net Issuance of Preferred Stock Historical Data

The historical data trend for Universal Ibogaine's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Net Issuance of Preferred Stock Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Jul24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Universal Ibogaine Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Universal Ibogaine Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Universal Ibogaine Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (FRA:JC4) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

IBOGF:USA IBO:Canada

Address

C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.

Universal Ibogaine Headlines

No Headlines